Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Annexon, Inc. ANNX |
Citadel Advisors LLC | 2,136,115 5.600% |
15,782 (+0.74%) |
Filing History |
| 2021-02-16 4:30 pm Unchanged |
2020-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Citadel Advisors LLC | 1,701,787 7.300% |
0 (Unchanged) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | Verastem, Inc. VSTM |
Citadel Advisors LLC | 25,487 0.200% |
-512,178 (-95.26%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | CAPITOL INVT CORP V COM CAP |
Citadel Advisors LLC | 1,869,059 5.400% |
1,869,059 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Simplify China A Shares PLUS Income ETF CAS |
Citadel Advisors LLC | 1,250,082 5.400% |
1,250,082 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX |
Citadel Advisors LLC | 6,660,717 3.800% |
-2,234,718 (-25.12%) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
Citadel Advisors LLC | 2,194,035 2.100% |
-1,198,589 (-35.33%) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | AVROBIO, Inc. AVRO |
Citadel Advisors LLC | 139,068 4.000% |
-1,684 (-1.20%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | SuRo Capital Corp. SSSS |
Citadel Advisors LLC | 1,276,990 6.100% |
169,174 (+15.27%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | CONCORD ACQUISI CORP CNDU |
Citadel Advisors LLC | 1,800,094 6.300% |
16 (+0.00%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | L&F Acquisition Corp. LNFA |
Citadel Advisors LLC | 870,009 5.000% |
3,072 (+0.35%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Bull Horn Holdings Corp. BHSE |
Citadel Advisors LLC | 623,209 6.500% |
623,209 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | Sutro Biopharma, Inc. STRO |
Citadel Advisors LLC | 1,301,804 2.900% |
-427,172 (-24.71%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Spring Valley Acquisition Corp. SV |
Citadel Advisors LLC | 1,346,600 5.900% |
1,346,600 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Citadel Advisors LLC | 1,503,870 3.700% |
-626,094 (-29.39%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | EdtechX Holdings Acquisition Corp. II EDTXU |
Citadel Advisors LLC | 550,558 4.800% |
460 (+0.08%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Periphas Capital Partnering Corporation PCPC |
Citadel Advisors LLC | 800,752 4.800% |
800,752 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Vincerx Pharma, Inc. VINC |
Citadel Advisors LLC | 31,897 4.500% |
31,897 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | PropTech Investment Corporation II PTIC |
Citadel Advisors LLC | 1,172,713 5.100% |
1,172,713 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Mudrick Capital Acquisition Corporation II MUDS |
Citadel Advisors LLC | 1,480,068 4.700% |
1,480,068 (New Position) |
Filing History |